Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Skunk Haze
- Development stage
- Unknown
- Lead developer
- CBD Crew
- Modality
- Small Molecules
- Administration
- Inhalation, Oral
01
Overview
Skunk Haze is a hybrid cannabis cultivar, traditionally a cross between Skunk #1 and Haze genetics. In the medical cannabis industry, it is most notably recognized as **CBD Skunk Haze**, a stabilized 1:1 THC:CBD variety developed by the **CBD Crew** (a collaboration between Mr. Nice Seeds and Resin Seeds). This balanced cannabinoid profile is intended to provide therapeutic relief for symptoms such as chronic pain, inflammation, and muscle spasticity while reducing the risk of THC-induced anxiety or paranoia. The strain's primary active components, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), interact with the human endocannabinoid system and various non-cannabinoid receptors. THC acts as a partial agonist at the CB1 and CB2 receptors, while CBD functions as a negative allosteric modulator of CB1 and an agonist at the 5-HT1A serotonin receptor, contributing to its analgesic and anxiolytic properties.
- Brand names
- CBD Skunk Haze
- Other names
- Skunk x Haze
02
Targets
CNR1 (Cannabinoid receptor 1)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))
Beyond the preview
Go deeper on Skunk Haze.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Skunk Haze.